Supernus Pharmaceuticals, Inc drugs

1 result
  • qelbree

    (viloxazine hydrochloride)
    Supernus Pharmaceuticals, Inc
    Qelbree is indicated for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in individuals aged 6 years and older, including adults.